* This programme is provisional and may be subject to change

 

Nov

25

Nov

26

Welcome
09:20  to  09:25

Dimitrios Chanouzas & Nina Brown

Management of ANCA associated Vasculitis (AAV)
09:25  to  10:35

Epidemiology of AAV - Fiona Pearce

Induction of Remission in AAV - Lorraine Harper

Maintenance of remission and treatment withdrawal in AAV - Dimitrios Chanouzas

Q&A

Chair - Steve McAdoo
 
EGPA Update
10:35  to  11:10

Update in the management of EGPA - Harry Wilson-Morkeh on behalf of BSR guideline group

Update on EGPA clinical trials - Ben Sutton

Q&A

Refreshment Break
11:10  to  11:25
Management of Large Vessel Vasculitis (LVV)
11:25  to  12:55

Takayasus's arteritis - Emma Derret-Smith

Polyarteritis nodosa - David Carruthers

Giant cell arteritis - Asad Khan

Ophthalmological involvement in GCA - Susie Mollan

Re-development of a UK Tertiary LVV Service - Andrew Porter

Chair: Taryn Youngstein
Lunch
13:00  to  13:45
Service considerations, patient perspectives and the role of the MDT
13:45  to  14:30

Rosemary Hollick, Sarah Hardy, Molly Bostock

Chair: Peter Lanyon

Vasculitis Specialist Nurse/MDT Session
14:30  to  17:30

An insight into Vasculitis specialist nursing - Sarah Hardy

Managing the ENT issues in an outpatient setting - an ENT workshop - Christine Burton, Chris Webb

Person Centred Care in Vasculitis - Sarah Logan

10 minute break

Vasculitis in Ethnic Minorities - Emma Dhillon

GCA scanning, a nurse perspective - Georgina Ducker

Developing an Online Program to Teach Guided Imagery for Managing Vasculitis: Results from a Patient Involvement Feasibility Study - Alice Muir

Questions

Vasculitis Research Session
14:30  to  17:30

Using genomic technologies in vasculitis research - Jimmy Peters

Machine Learning to Drive AAV Research - Mark Little

Rare AutoImmune Self-management programme development (RAISE) - Jo Robson

Break 10 mins

Prediction in ANCA GN – Current tools and outlook - Silke Brix

5 research talks (Vasculitis UK Bursary recipients)

Cocaine associated granulomatosis with polyangiitis is phenotypically distinct - Deniz Koku

Comparing outcomes of rituximab versus cyclophosphamide for induction of remission in ANCA associated vasculitis with severe kidney involvement - Nishant Chaudhari

Retrospective analysis of ocular manifestations of systemic vasculitis: insights from a single tertiary centre - Lucy Hong

Pneumococcal vaccine responses in patients with ANCA associated vasculitis: results of the ACQUIVAS trial - Michael Chen-Xu

ATLANTIS – Identification of autoimmunity reversal in ANCA vasculitis - Eithne Nic an Riogh

Chair: Rona Smith
Justin Mason Memorial Lecture
17:30  to  18:15

Richard Watts